Similar to EGFR mutations, Anaplastic Lymphoma Kinase (ALK) (typically translocations) typically occurs in non-smoker NSCLC patients with adenocarcinoma histotype in approximately 3–5% of NSCLC cases [117,118]. This evidence concerns the gene ALK and non-small cell lung carcinoma.